XSHE
000504
Market cap564mUSD
Oct 09, Last price
11.79CNY
1D
2.97%
1Q
46.28%
Jan 2017
-28.85%
Name
Hunan CCID-Media Investments Co Ltd
Chart & performance
P/E
134.97
P/S
9.35
EPS
0.09
Div yield, %
—
Shrs. gr., 5y
0.56%
Rev. gr., 5y
21.57%
Revenues
416m
+209.37%
Net income
29m
P
CFO
-116m
L
Dividend
Apr 23, 20040.023077 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Landfar Bio-medicine Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It also involves in the storage of biological resources, stem cells and immune cells. The company was founded in November 1988 and is headquartered in Changsha, China.
Key people
Lei Shi
Chairman of the Board · since 2015
Pengbin Lin
Finance Director · since 2015
Qinmin Wu
Deputy General Manager · since 2008
Zhibo Han
Deputy General Manager, Director · since 2012
Zhigang Huang
Director · since 2011
Fang Liu
Director · since 2012
Xiaoping Lu
Director · since 2013
Yifeng Jia
Independent Director · since 2008
Independent Director · since 2010
Independent Director · since 2011
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||